國立虎尾科技大學 |

Disorders of Blood Pressure Regulation = Phenotypes, Mechanisms, Therapeutic Options /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Disorders of Blood Pressure Regulation/ edited by Adel E. Berbari, Giuseppe Mancia.
其他題名:	Phenotypes, Mechanisms, Therapeutic Options /
其他作者:	Berbari, Adel E.
面頁冊數:	XI, 880 p. 131 illus., 53 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cardiology. -
電子資源:	https://doi.org/10.1007/978-3-319-59918-2
ISBN:	9783319599182

Disorders of Blood Pressure Regulation = Phenotypes, Mechanisms, Therapeutic Options /
Disorders of Blood Pressure RegulationPhenotypes, Mechanisms, Therapeutic Options /[electronic resource] :edited by Adel E. Berbari, Giuseppe Mancia. - 1st ed. 2018. - XI, 880 p. 131 illus., 53 illus. in color.online resource. - Updates in Hypertension and Cardiovascular Protection,2366-4606. - Updates in Hypertension and Cardiovascular Protection,.

Part I: General Aspects -- 1. Introduction: Definition and Classification of Arterial Pressure Phenotypes -- 2. Diagnostic and Prognostic Significance of Blood Pressure Indices -- 3. Role of Circadian Rhythms and Seasonal Variation in BP Levels -- 4. Natural History of Treated and Untreated Hypertension -- Part II: Mechanisms of Hypertension Development -- 5. The Kidneys, Volume and Blood Pressure Regulation, and Hypertension -- 6. Nervous System -- 7. Hormonal Systems -- 8. Vasoactive Peptides -- 9. Endothelial Function -- 10. Genetics of Blood Pressure and Hypertension -- Part III: Hypertension Phenotypes: Monogenic Syndromes -- 11. Monogenic Forms of Hypertension -- 12. Arterial Hypertension in Turner Syndrome -- Part IV: Hypertension Phenotypes: The Heart -- 13. Hypertensive Heart Disease -- 14. Perioperative Cardiac Surgery Hypertension -- 15. Hypertension: Supravalvular Aortic Stenosis -- 16. Coarctation of the Aorta -- 17. Atrial Fibrillation and Hypertension: Two Entities That Usually Coexist -- Part V: Hypertension Phenotypes: The Central Nervous System and the Brain -- 18. Sleep Disturbances/Sleep Apnea -- 19. Stress and Hypertension -- 20. Central Nervous System Disorders: Transient Ischemic Attack and Stroke (Ischemic/Hemorrhagic) -- Part VI: Hypertension Phenotypes: The Kidney -- 21. Chronic Kidney Disease -- 22. Calculus Renal Disease -- 23. Uric Acid-Hypertension Relationships -- 24. Hypertension in Dialysis Patients: Clinical Edidemiology, Pathogenesis, Diagnosis, and Treatment -- 25. Renovascular Hypertension -- 26. Molecular Pathways in Hypertensive Renal Damage.- 27. Determinants of Hypertensive Renal Disease and Its Progression -- Part VII: Hypertension Phenotypes: Endocrine Causes -- 28. Cushing's Syndrome and Glucocorticoid Excess -- 29. Primary Aldosteronism and Its Various Scenarios -- 30. Severe Paroxysmal Hypertension (Pseudopheochromocytoma) -- 31. Paroxysmal Hypertension: Pheochromocytoma -- 32. Hypertension in Thyroid Disorders -- 33. Primary Hyperparathyroidism -- Part VIII: Special Types of Hypertension -- 34. Phenotypic Changes in the Transition from Prehypertension to Established Hypertension -- 35. White Coat and Masked Hypertension -- 36. Isolated Systolic Hypertension: In the Young and in the Elderly -- 37. Treatment of Resistant Hypertension -- 38. Accelerated / Malignant Hypertension -- 39. Nocturnal Hypertension -- 40. Salt and Hypertension -- 41. Diabetes Mellitus and Hypertension -- 42. Obesity and Metabolic Syndrome Hypertension -- 43. Secondary Hypertension: Infrequently Considered Aspects—Illicit/Recreational Substances, Herbal Remedies, and Drug-Associated Hypertension -- Part IX: Hypertensive Phenotypes: Blood Pressure Disorders of Pregnancy and Pediatric Hypertension -- 44. Hypertensive Disorders of Pregnancy -- 45. Blood Pressure Trends in Children and Adolescents: Predictors of Blood Pressure Elevation in Children and Adolescents -- 46. Hypertension in Children and Adolescents -- Part X: Management and Therapeutic Approaches -- 47. What Is New and What Is Different in Recent Guidelines on Antihypertensive Treatment? Looking Forward to Guidelines Reappraisal -- 48. Place of Invasive Procedures in Blood Pressure Control -- 49. Is Hypertension-Related Target Organ Involvement/Damage Reversible/Preventable?

This book aims to present a comprehensive classification of hypertensive phenotypes based on underlying target organ involvement. Particular emphasis is placed on review and assessment of clinical presentation, pathophysiologic mechanisms, and possible specific therapeutic options for each hypertension phenotype. Several of these phenotypes are well known and well described in the literature, such as prehypertension, white coat and masked hypertension, isolated systolic hypertension, renovascular hypertension, endocrine hypertension, pediatric hypertension, and gestational hypertension. Other hypertension phenotypes, however, are not widely recognized, being reported only in special reviews; examples include hypertension associated with renal calculus disease and other rarer causes such as Turner syndrome, herbal and medicinal compounds, and pharmacologic agents. A detailed account of the various causes of monogenic hypertension is also included. Finally, a section is devoted to general aspects of hypertension, including the significance of blood pressure indices, the natural course of untreated and treated hypertension, hypertension mechanisms, genetics, and guidelines for blood pressure control. .

ISBN: 9783319599182

Standard No.: 10.1007/978-3-319-59918-2doiSubjects--Topical Terms:

593957
Cardiology.

LC Class. No.: RC681-688.2

Dewey Class. No.: 616.12

Disorders of Blood Pressure Regulation = Phenotypes, Mechanisms, Therapeutic Options /
LDR:06016nam a22004095i 4500 001 994156
003 DE-He213
005 20200704013024.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319599182 $9 978-3-319-59918-2
024 7 $a 10.1007/978-3-319-59918-2 $2 doi
035 $a 978-3-319-59918-2
050 4 $a RC681-688.2
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.12 $2 23
245 1 0 $a Disorders of Blood Pressure Regulation $h [electronic resource] : $b Phenotypes, Mechanisms, Therapeutic Options / $c edited by Adel E. Berbari, Giuseppe Mancia.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XI, 880 p. 131 illus., 53 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Updates in Hypertension and Cardiovascular Protection, $x 2366-4606
505 0 $a Part I: General Aspects -- 1. Introduction: Definition and Classification of Arterial Pressure Phenotypes -- 2. Diagnostic and Prognostic Significance of Blood Pressure Indices -- 3. Role of Circadian Rhythms and Seasonal Variation in BP Levels -- 4. Natural History of Treated and Untreated Hypertension -- Part II: Mechanisms of Hypertension Development -- 5. The Kidneys, Volume and Blood Pressure Regulation, and Hypertension -- 6. Nervous System -- 7. Hormonal Systems -- 8. Vasoactive Peptides -- 9. Endothelial Function -- 10. Genetics of Blood Pressure and Hypertension -- Part III: Hypertension Phenotypes: Monogenic Syndromes -- 11. Monogenic Forms of Hypertension -- 12. Arterial Hypertension in Turner Syndrome -- Part IV: Hypertension Phenotypes: The Heart -- 13. Hypertensive Heart Disease -- 14. Perioperative Cardiac Surgery Hypertension -- 15. Hypertension: Supravalvular Aortic Stenosis -- 16. Coarctation of the Aorta -- 17. Atrial Fibrillation and Hypertension: Two Entities That Usually Coexist -- Part V: Hypertension Phenotypes: The Central Nervous System and the Brain -- 18. Sleep Disturbances/Sleep Apnea -- 19. Stress and Hypertension -- 20. Central Nervous System Disorders: Transient Ischemic Attack and Stroke (Ischemic/Hemorrhagic) -- Part VI: Hypertension Phenotypes: The Kidney -- 21. Chronic Kidney Disease -- 22. Calculus Renal Disease -- 23. Uric Acid-Hypertension Relationships -- 24. Hypertension in Dialysis Patients: Clinical Edidemiology, Pathogenesis, Diagnosis, and Treatment -- 25. Renovascular Hypertension -- 26. Molecular Pathways in Hypertensive Renal Damage.- 27. Determinants of Hypertensive Renal Disease and Its Progression -- Part VII: Hypertension Phenotypes: Endocrine Causes -- 28. Cushing's Syndrome and Glucocorticoid Excess -- 29. Primary Aldosteronism and Its Various Scenarios -- 30. Severe Paroxysmal Hypertension (Pseudopheochromocytoma) -- 31. Paroxysmal Hypertension: Pheochromocytoma -- 32. Hypertension in Thyroid Disorders -- 33. Primary Hyperparathyroidism -- Part VIII: Special Types of Hypertension -- 34. Phenotypic Changes in the Transition from Prehypertension to Established Hypertension -- 35. White Coat and Masked Hypertension -- 36. Isolated Systolic Hypertension: In the Young and in the Elderly -- 37. Treatment of Resistant Hypertension -- 38. Accelerated / Malignant Hypertension -- 39. Nocturnal Hypertension -- 40. Salt and Hypertension -- 41. Diabetes Mellitus and Hypertension -- 42. Obesity and Metabolic Syndrome Hypertension -- 43. Secondary Hypertension: Infrequently Considered Aspects—Illicit/Recreational Substances, Herbal Remedies, and Drug-Associated Hypertension -- Part IX: Hypertensive Phenotypes: Blood Pressure Disorders of Pregnancy and Pediatric Hypertension -- 44. Hypertensive Disorders of Pregnancy -- 45. Blood Pressure Trends in Children and Adolescents: Predictors of Blood Pressure Elevation in Children and Adolescents -- 46. Hypertension in Children and Adolescents -- Part X: Management and Therapeutic Approaches -- 47. What Is New and What Is Different in Recent Guidelines on Antihypertensive Treatment? Looking Forward to Guidelines Reappraisal -- 48. Place of Invasive Procedures in Blood Pressure Control -- 49. Is Hypertension-Related Target Organ Involvement/Damage Reversible/Preventable?
520 $a This book aims to present a comprehensive classification of hypertensive phenotypes based on underlying target organ involvement. Particular emphasis is placed on review and assessment of clinical presentation, pathophysiologic mechanisms, and possible specific therapeutic options for each hypertension phenotype. Several of these phenotypes are well known and well described in the literature, such as prehypertension, white coat and masked hypertension, isolated systolic hypertension, renovascular hypertension, endocrine hypertension, pediatric hypertension, and gestational hypertension. Other hypertension phenotypes, however, are not widely recognized, being reported only in special reviews; examples include hypertension associated with renal calculus disease and other rarer causes such as Turner syndrome, herbal and medicinal compounds, and pharmacologic agents. A detailed account of the various causes of monogenic hypertension is also included. Finally, a section is devoted to general aspects of hypertension, including the significance of blood pressure indices, the natural course of untreated and treated hypertension, hypertension mechanisms, genetics, and guidelines for blood pressure control. .
650 0 $a Cardiology. $3 593957
650 0 $a Angiology. $3 668966
650 0 $a Nephrology. $3 668354
650 0 $a Endocrinology . $3 1254221
650 0 $a Neurology . $3 1253459
650 0 $a Human physiology. $3 636012
650 2 4 $a Endocrinology. $3 645497
650 2 4 $a Neurology. $3 593894
650 2 4 $a Human Physiology. $3 668349
700 1 $a Berbari, Adel E. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 882720
700 1 $a Mancia, Giuseppe. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 777973
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319599175
776 0 8 $i Printed edition: $z 9783319599199
776 0 8 $i Printed edition: $z 9783319867342
830 0 $a Updates in Hypertension and Cardiovascular Protection, $x 2366-4606 $3 1268130
856 4 0 $u https://doi.org/10.1007/978-3-319-59918-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)